Societe Generale-FORGE Launches EUR Coinvertible on XRP Ledger With Ripple SupportFebruary 19, 2026Bitcoin.com
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and IngrezzaFebruary 19, 2026Yahoo Finance
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and IngrezzaFebruary 19, 2026Yahoo Finance
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase IIIFebruary 19, 2026Yahoo Finance
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase IIIFebruary 19, 2026Yahoo Finance
Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.’s (DFTX) DT120 in Phase IIIFebruary 19, 2026Yahoo Finance
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model UpdatesFebruary 19, 2026Yahoo Finance
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model UpdatesFebruary 19, 2026Yahoo Finance
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model UpdatesFebruary 19, 2026Yahoo Finance
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model UpdatesFebruary 19, 2026Yahoo Finance
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model UpdatesFebruary 19, 2026Yahoo Finance